TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Shanghai Heartcare Medical Technology Corp. Ltd. Class H ( (HK:6609) ) has provided an update.
Shanghai HeartCare Medical Technology Corp. Ltd. successfully held its 2024 Annual General Meeting (AGM) and Extraordinary General Meeting (EGM) on May 26, 2025, where all proposed resolutions were passed by poll. The meetings were conducted in compliance with the Company Law of the PRC and the Articles of Association, with significant shareholder participation, indicating robust governance and stakeholder engagement.
The most recent analyst rating on (HK:6609) stock is a Buy with a HK$25.60 price target. To see the full list of analyst forecasts on Shanghai Heartcare Medical Technology Corp. Ltd. Class H stock, see the HK:6609 Stock Forecast page.
More about Shanghai Heartcare Medical Technology Corp. Ltd. Class H
Shanghai HeartCare Medical Technology Corp. Ltd. is a company based in the People’s Republic of China, operating in the medical technology industry. It focuses on developing medical solutions and technologies, with a market presence that includes both H Shares and Unlisted Shares.
Average Trading Volume: 14,335
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.05B
Learn more about 6609 stock on TipRanks’ Stock Analysis page.